Jimtash, there is one big difference between the 2011 and the 2013 UNI deals.
The 2013 deal transfers all the manufacturing knowhow and the rights to manufacture the test. Once that transfer of technology is done, Radient no longer needs to exist as a test manufacturer.
Also, in the agreement, UNI was supposedly be responsible for continuing all of the patent applications for the 2010 application. What would be the reason UNI allowed the WIP patent application to lapse for not paying fees?
Also, UNI only has to pay the 100k per year as long as patents or patent applications exist. The second patent for DR70 expires in April 2014 and if UNI also allows the US patent application to lapse, they would not need to pay any royalty at all.
Did you notice that Radient cannot even sue UNI if they don't comply with the contract?
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
